Medius Holdings Co., Ltd. Logo

Medius Holdings Co., Ltd.

3154.T

(2.2)
Stock Price

779,00 JPY

1% ROA

5.93% ROE

15.27x PER

Market Cap.

18.990.604.668,00 JPY

122.48% DER

2.46% Yield

0.43% NPM

Medius Holdings Co., Ltd. Stock Analysis

Medius Holdings Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Medius Holdings Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.95x), the stock offers substantial upside potential at a bargain price.

2 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 ROE

ROE in an average range (6.36%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (1.23%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.

7 Dividend

Investors can take comfort in the fact that the company has consistently distributed dividends over the past three years, demonstrating a commitment to rewarding shareholders.

8 DER

The stock is burdened with a heavy load of debt (103%), making it financially unstable and potentially risky for investors.

9 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-375.267) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Medius Holdings Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Medius Holdings Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Medius Holdings Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Medius Holdings Co., Ltd. Revenue
Year Revenue Growth
2009 58.599.294.000
2010 120.395.068.000 51.33%
2011 132.833.577.000 9.36%
2012 134.010.543.000 0.88%
2013 145.969.388.000 8.19%
2014 146.168.943.000 0.14%
2015 158.400.395.000 7.72%
2016 162.654.100.000 2.62%
2017 168.135.875.000 3.26%
2018 197.691.482.000 14.95%
2019 210.388.116.000 6.03%
2020 246.787.302.000 14.75%
2021 221.694.333.000 -11.32%
2022 239.054.420.000 7.26%
2023 266.689.196.000 10.36%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Medius Holdings Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Medius Holdings Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 376.179.000
2010 885.629.000 57.52%
2011 836.325.000 -5.9%
2012 870.524.000 3.93%
2013 985.905.000 11.7%
2014 1.073.873.000 8.19%
2015 1.232.978.000 12.9%
2016 1.359.338.000 9.3%
2017 1.566.775.000 13.24%
2018 1.923.745.000 18.56%
2019 2.111.159.000 8.88%
2020 1.923.853.000 -9.74%
2021 2.181.495.000 11.81%
2022 2.354.159.000 7.33%
2023 2.747.404.000 14.31%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Medius Holdings Co., Ltd. EBITDA
Year EBITDA Growth
2009 2.120.695.000
2010 4.026.546.000 47.33%
2011 4.519.162.000 10.9%
2012 5.279.927.000 14.41%
2013 5.807.467.000 9.08%
2014 5.263.249.000 -10.34%
2015 5.182.272.000 -1.56%
2016 5.145.540.000 -0.71%
2017 2.116.979.000 -143.06%
2018 2.249.162.000 5.88%
2019 2.317.417.000 2.95%
2020 4.117.399.000 43.72%
2021 3.992.567.000 -3.13%
2022 4.179.340.000 4.47%
2023 692.332.000 -503.66%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Medius Holdings Co., Ltd. Gross Profit
Year Gross Profit Growth
2009 6.446.522.000
2010 12.506.863.000 48.46%
2011 13.249.255.000 5.6%
2012 13.938.710.000 4.95%
2013 15.013.872.000 7.16%
2014 15.244.422.000 1.51%
2015 16.071.197.000 5.14%
2016 16.571.141.000 3.02%
2017 17.116.305.000 3.19%
2018 20.113.206.000 14.9%
2019 22.272.813.000 9.7%
2020 25.196.932.000 11.61%
2021 27.420.767.000 8.11%
2022 29.305.369.000 6.43%
2023 29.757.884.000 1.52%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Medius Holdings Co., Ltd. Net Profit
Year Net Profit Growth
2009 456.522.000
2010 245.358.000 -86.06%
2011 447.421.000 45.16%
2012 896.227.000 50.08%
2013 968.569.000 7.47%
2014 433.295.000 -123.54%
2015 899.912.000 51.85%
2016 863.221.000 -4.25%
2017 741.715.000 -16.38%
2018 -70.096.000 1158.14%
2019 951.357.000 107.37%
2020 2.065.996.000 53.95%
2021 1.867.916.000 -10.6%
2022 1.498.008.000 -24.69%
2023 -85.404.000 1854.03%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Medius Holdings Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 86
2010 14 -561.54%
2011 26 48%
2012 52 51.92%
2013 56 5.45%
2014 23 -139.13%
2015 46 50%
2016 44 -4.55%
2017 38 -15.79%
2018 -3 1366.67%
2019 44 106.98%
2020 95 54.26%
2021 85 -10.59%
2022 68 -25%
2023 -4 1800%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Medius Holdings Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2009 -179.947.000
2010 -2.076.103.000 91.33%
2011 3.571.173.000 158.14%
2012 329.868.000 -982.61%
2013 2.529.498.000 86.96%
2014 -1.343.847.000 288.23%
2015 2.451.211.000 154.82%
2016 2.300.783.000 -6.54%
2017 565.014.000 -307.21%
2018 -1.859.425.000 130.39%
2019 185.142.000 1104.32%
2020 2.934.051.000 93.69%
2021 -8.488.056.000 134.57%
2022 300.654.000 2923.2%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Medius Holdings Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2009 651.982.000
2010 -985.603.000 166.15%
2011 3.889.918.000 125.34%
2012 576.065.000 -575.26%
2013 3.045.200.000 81.08%
2014 -962.560.000 416.36%
2015 2.628.060.000 136.63%
2016 2.447.772.000 -7.37%
2017 722.998.000 -238.56%
2018 -1.084.620.000 166.66%
2019 1.169.117.000 192.77%
2020 6.848.544.000 82.93%
2021 -3.899.003.000 275.65%
2022 1.224.486.000 418.42%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Medius Holdings Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2009 831.929.000
2010 1.090.500.000 23.71%
2011 318.745.000 -242.12%
2012 246.197.000 -29.47%
2013 515.702.000 52.26%
2014 381.287.000 -35.25%
2015 176.849.000 -115.6%
2016 146.989.000 -20.31%
2017 157.984.000 6.96%
2018 774.805.000 79.61%
2019 983.975.000 21.26%
2020 3.914.493.000 74.86%
2021 4.589.053.000 14.7%
2022 923.832.000 -396.74%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Medius Holdings Co., Ltd. Equity
Year Equity Growth
2009 4.920.102.000
2010 5.381.809.000 8.58%
2011 5.612.154.000 4.1%
2012 6.462.677.000 13.16%
2013 7.305.066.000 11.53%
2014 8.519.975.000 14.26%
2015 9.290.431.000 8.29%
2016 9.799.057.000 5.19%
2017 10.633.674.000 7.85%
2018 12.684.655.000 16.17%
2019 13.873.182.000 8.57%
2020 15.843.152.000 12.43%
2021 17.307.763.000 8.46%
2022 18.572.068.000 6.81%
2023 19.737.425.000 5.9%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Medius Holdings Co., Ltd. Assets
Year Assets Growth
2009 19.089.757.000
2010 39.330.083.000 51.46%
2011 43.852.221.000 10.31%
2012 40.180.931.000 -9.14%
2013 43.272.878.000 7.15%
2014 46.493.144.000 6.93%
2015 47.936.988.000 3.01%
2016 47.452.699.000 -1.02%
2017 53.749.914.000 11.72%
2018 62.001.758.000 13.31%
2019 69.970.969.000 11.39%
2020 84.437.162.000 17.13%
2021 92.953.841.000 9.16%
2022 97.455.753.000 4.62%
2023 114.826.794.000 15.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Medius Holdings Co., Ltd. Liabilities
Year Liabilities Growth
2009 14.169.655.000
2010 33.948.274.000 58.26%
2011 38.240.067.000 11.22%
2012 33.718.254.000 -13.41%
2013 35.967.812.000 6.25%
2014 37.973.169.000 5.28%
2015 38.646.557.000 1.74%
2016 37.653.642.000 -2.64%
2017 43.116.240.000 12.67%
2018 49.317.103.000 12.57%
2019 56.097.787.000 12.09%
2020 68.594.010.000 18.22%
2021 75.646.078.000 9.32%
2022 78.883.685.000 4.1%
2023 95.089.365.000 17.04%

Medius Holdings Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
12919.49
Net Income per Share
55.93
Price to Earning Ratio
15.27x
Price To Sales Ratio
0.07x
POCF Ratio
6.75
PFCF Ratio
7.46
Price to Book Ratio
0.87
EV to Sales
0.11
EV Over EBITDA
9.61
EV to Operating CashFlow
11.6
EV to FreeCashFlow
11.6
Earnings Yield
0.07
FreeCashFlow Yield
0.13
Market Cap
18,99 Bil.
Enterprise Value
29,52 Bil.
Graham Number
1111.41
Graham NetNet
-1331.82

Income Statement Metrics

Net Income per Share
55.93
Income Quality
3
ROE
0.06
Return On Assets
0.01
Return On Capital Employed
0.04
Net Income per EBT
0.58
EBT Per Ebit
1.48
Ebit per Revenue
0.01
Effective Tax Rate
0.42

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.12
Operating Profit Margin
0.01
Pretax Profit Margin
0.01
Net Profit Margin
0

Dividends

Dividend Yield
0.02
Dividend Yield %
2.46
Payout Ratio
0
Dividend Per Share
21

Operating Metrics

Operating Cashflow per Share
126.52
Free CashFlow per Share
126.52
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.02
Return on Tangible Assets
0.01
Days Sales Outstanding
90.42
Days Payables Outstanding
95.85
Days of Inventory on Hand
20.31
Receivables Turnover
4.04
Payables Turnover
3.81
Inventory Turnover
17.98
Capex per Share
0

Balance Sheet

Cash per Share
679,39
Book Value per Share
981,56
Tangible Book Value per Share
842.79
Shareholders Equity per Share
981.56
Interest Debt per Share
1207.12
Debt to Equity
1.22
Debt to Assets
0.21
Net Debt to EBITDA
3.43
Current Ratio
1.08
Tangible Asset Value
16,95 Bil.
Net Current Asset Value
-3,84 Bil.
Invested Capital
21794063000
Working Capital
6,93 Bil.
Intangibles to Total Assets
0.02
Average Receivables
62,32 Bil.
Average Payables
61,01 Bil.
Average Inventory
12556738500
Debt to Market Cap
1.27

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Medius Holdings Co., Ltd. Dividends
Year Dividends Growth
2010 100
2011 100 0%
2012 40 -150%
2013 75 46.67%
2014 80 6.25%
2015 80 0%
2018 10 -700%
2019 14 28.57%
2020 14 0%
2021 14 0%
2022 19 26.32%
2023 22 13.64%
2024 21 -4.76%
2025 0 0%

Medius Holdings Co., Ltd. Profile

About Medius Holdings Co., Ltd.

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.

CEO
Mr. Yasuhiko Ikeya
Employee
2.517
Address
1-1-1 Kyobashi
Tokyo, 104-0031

Medius Holdings Co., Ltd. Executives & BODs

Medius Holdings Co., Ltd. Executives & BODs
# Name Age
1 Mr. Hiroyuki Akutagawa
Senior Managing Executive Officer, GM of Corporate Management Headquarters & Director
70
2 Mr. Shuhei Miyaji
Senior Managing Executive Officer & GM of Presidential Division & Director
70
3 Mr. Hiroto Takei
Manager of Presidential Division & Director
70
4 Mr. Masaru Kuribara
Senior Managing Executive Officer & Director
70
5 Mr. Hisayuki Furuki
Managing Executive Officer & Director
70
6 Mr. Yasuhiko Ikeya
Chief Executive Officer, President & Representative Director
70
7 Mr. Shinya Sumiyoshi
Senior Managing Executive Officer & Director
70
8 Mr. Satoru Umesawa
Senior Managing Executive Officer and Director
70

Medius Holdings Co., Ltd. Competitors